Product NDC: | 0069-0027 |
Proprietary Name: | Ampicillin |
Non Proprietary Name: | Ampicillin Sodium |
Active Ingredient(s): | 125 mg/1 & nbsp; Ampicillin Sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0027 |
Labeler Name: | Pfizer Laboratories, Division of Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065499 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100817 |
Package NDC: | 0069-0027-10 |
Package Description: | 10 VIAL in 1 BOX (0069-0027-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0069-0027-12) |
NDC Code | 0069-0027-10 |
Proprietary Name | Ampicillin |
Package Description | 10 VIAL in 1 BOX (0069-0027-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0069-0027-12) |
Product NDC | 0069-0027 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ampicillin Sodium |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20100817 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories, Division of Pfizer Inc |
Substance Name | AMPICILLIN SODIUM |
Strength Number | 125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |